You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

You’ve been redirected to the new Cancer Care Ontario website. You can also visit the archived website, which is no longer being maintained.

The Use of FOLFIRINOX as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

ID: 2-18 Jun 2011
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
Gastrointestinal Cancer Disease Site Group